Hello Avatar! Welcome to another week of biotech analysis. Today’s commentary is as always on Thursday focused on the general market update. However, given it is a short week, and everyone has gone skiing, we won’t be diving into market insights today. With the markets winding down, we’re taking this opportunity to spotlight the top articles of 2024. If…
Keep reading with a 7-day free trial
Subscribe to BowTiedBiotech to keep reading this post and get 7 days of free access to the full post archives.